Browse > Article
http://dx.doi.org/10.5352/JLS.2006.16.5.759

Different Responses to Arsenic Trioxide between NB4 and UF-1, Acute Promyelocytic Leukemia Cell Lines  

Kim, Hye-Ran (Department of Microbiology, College of Medicine Dong-A University)
Choi, Yoon-Jeong (Department of Microbiology, College of Medicine Dong-A University)
Ryu, Seong-Yeoll (Department of Microbiology, College of Medicine Dong-A University)
Lee, Young-Seok (Department of Pediatrics, College of Medicine Dong-A University)
Lee, Sang-Hwa (Department of Microbiology, College of Medicine Dong-A University)
Publication Information
Journal of Life Science / v.16, no.5, 2006 , pp. 759-766 More about this Journal
Abstract
Acute promyelocytic leukemia (APL) is a myeloid leukemia caused by over-expression of fusion protein, PML/RAR$({\alpha})$, which was the result of chromosomal translocation and induces the blockage of differentiation of affected promyelocytes. Pharmacological dose of retinoic acid induces the activation of and subsequent degradation of PML/RAR$({\alpha})$ fusion protein, and then APL cells undergo through the normal differentiation pathway. Arsenic trioxide has proved effective in causing remission of acute promyelocytic leukemia by inducing apoptosis of this tumor cells, whereas the heterogeneity of cellular susceptibility to this cytotoxic agent limited its usage on more types of tumors in clinic. This work showed that arsenic trioxide could induce apoptosis of a panel of acute promyelocytic leukemic cell lines, all-trans-retinoic acid (ATRA) sensitive NB4 cells and ATRA resistant UF-1 cell. They were investigated with regard to the correlation between the inherent or intrinsic cellular level of GSH and the apoptotic susceptibility of the cells to arsenic trioxide. We manifested, in two cell types, the inherently existed difference in intracellular GSH level reactive to the arsenic trioxide, and a positive correlation between the GSH level and their apoptotic sensitivity to arsenic trioxide. And it showed that arsenic trioxide could differentiate promyelocytic cancer cells to the cells possessed of dendritic cell surface markers. Unravelling the cause of the different susceptibility between leukemic cells and proving that promyelocyte could be differentiated to dendritic cells by arsenic trioxide will help not only to understand the mechanism underlying the complete remission of acute promyelocytic leukemia induced by arsenic trioxide, but also to expand its clinical usage.
Keywords
Acute promyelocytic leukemia; dendritic cell surface markers; arsenic trioxide;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Cavigelli M., W. W. Li, A. Lin, B. Su, K. Yoshioka and M. Karin. 1996. The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase. EMBO J. 15, 6269-6279
2 Lanotte M., V. Martin-Thouvenin, S. Najman, P. Balerini, F. Varensi and R. Berger. 1991. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia(M3). Blood 77, 1080-1086
3 Miller W. H., R. P. Warrel, S. R. Frankel, A. Jakubowski, J. L. Gabrilove, J. Muindi and E. Dmitrovsky.1990. Novel retinoic acid receptor - a transcripts in acute promyelocytic leukemia responsive to all-trans-retinoic acid. J. Natl. Cancer Inst. 32, 1932-1933
4 Namgung U and Z. Xia. 2000. Arsenite-induced apoptosis in cortical neurons is mediated by c-Jun N-terminal protein kinase 3 and p38 mitogen-activated protein kinase. J. Neurosci. 20, 6442-6451   DOI
5 Dai J, R. S. Weinberg, S. Waxman and Y. Jing. 1999. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood 93, 268-277
6 Kakizuka, A., W. H. Miller, K. Umesono, R. P. Warrell, S. R. Frankel, V. V. Murty, E. Dmitrovsky and R. M. Evans. 1991. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 66, 663-674   DOI   ScienceOn
7 Soignet S., A. Fleischauer, T. Polyak, G. Heller and R. P. Warrel. 1997. All-trans retinoic acid significantly increases 50 year survival in patients with acute promyelocytic leukemia: long-term follow-up of the New York study. Cancer Chemother. Pharmacol. 40, S25-S29   DOI
8 Terstappern L. W., Z. Hollander, H. Meiners and M. R. Loken. 1990. Quantitative comparison of myeloid antigens on five lineages of mature peripheral blood cells. J. Leukoc. Biol. 48, 138-148   DOI
9 Warrel R. P. 1993. Retinoid resistance in acute promyelocytic leukemia: New mechanisms, strategies and implications. Blood 82, 2175-2181
10 Chen, G. Q., J. Zhu, X. G. Shi, H. J. Zhong, G. Y. Si, X. L. Jin, W. Tang, X. S. Li, S. M. Xong, Z. X. Shen, G. L. Sun, J. Ma, P. Zhang, T. D. Zhang, C. Gazin, T. Naoe and Z. Chen. 1996. In vitro sutdies on cellular and molecular mechanisms of arsenic trioxide $(As_2O_3)$ in the treatment of acute promyelocytic leukemia : As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of $PML/RAR{\alpha}/PML$ proteins. Blood 88, 1052-1061
11 Davison K., S. Cote, S. Mader and W. H. Miller. 2003. Glutathione depletion overcomes resistance to arsenic trioxide in arsenic-resistant cell lines. Leukemia 17, 931-940   DOI   ScienceOn
12 de The H., C. Chomienne, M. Lanotte, I. Degos and A. Dejean. 1990. The t(15;17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor ${\alpha}$ gene to a novel transcribed locus. Nature 347, 558-561   DOI   ScienceOn
13 de The H., C. Lacau, A. Marchio, C. Chomienne, L. Degos and A. Dejean. 1991. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66, 675-684   DOI   ScienceOn
14 Jing Y., J. Dai, R. M .E. Chalmers-Redman, W. G. Tatton and S. Waxman. 1999. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Blood 94, 2102-2111
15 Borrow J., A. D. Goddard, D. Sheer and E. Solomon. 1990. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 249, 1557-80
16 Cignetti A., E. Bryant, B. Allione, A. Vitale, R. Foa and M. A. Cheever. 1999. CD34(+) acute myeloid and lymphoid leukemic blasts can be induced to differentiate into dendritic cells. Blood 94, 2048-2055
17 Bennett J. M., D. Catovsky, M. T. Daniel, G. Flandrin, D. A. G. Galton, H. R. Grolnick and C. Sultan. 1985. Proposed revised criteria for the classification of acute myeloid leukemia. Ann. Intern. Med. 103, 620-625   DOI   ScienceOn